Literature DB >> 20939568

A unique approach to the concise synthesis of highly optically active spirooxazolines and the discovery of a more potent oxindole-type phytoalexin analogue.

Xianxing Jiang1, Yiming Cao, Yiqing Wang, Luping Liu, Fangfang Shen, Rui Wang.   

Abstract

Drug-lead synthesis through rapid construction of chiral molecular complexity around the biologically relevant framework using a highly efficient strategy is a key goal of organic synthesis. Molecules bearing a spirooxindole-type framework exhibit important bioactivities. Herein, we present a highly efficient and convenient strategy that allows rapid construction of unique optically active spiro[oxazoline-3,3'-oxindole]s through the organocatalyzed asymmetric synthesis of spirocyclic thiocarbamates via an aldol reaction. Preliminary biological evaluation of several of the spirooxazolines using a model of acute neuroinflammation revealed promising antipyretic activity and provided an opportunity to discover new antipyretic agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20939568     DOI: 10.1021/ja106349m

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  18 in total

1.  Asymmetric synthesis of allenyl oxindoles and spirooxindoles by a catalytic enantioselective Saucy-Marbet Claisen rearrangement.

Authors:  Trung Cao; Joshua Deitch; Elizabeth C Linton; Marisa C Kozlowski
Journal:  Angew Chem Int Ed Engl       Date:  2012-01-27       Impact factor: 15.336

2.  Enantioselective Pictet-Spengler Reactions of Isatins for the Synthesis of Spiroindolones.

Authors:  Joseph J Badillo; Abel Silva-García; Benjamin H Shupe; James C Fettinger; Annaliese K Franz
Journal:  Tetrahedron Lett       Date:  2011-10-26       Impact factor: 2.415

3.  Copper(II)- and palladium(II)-catalyzed enantioselective Claisen rearrangement of allyloxy- and propargyloxy-indoles to quaternary oxindoles and spirocyclic lactones.

Authors:  Trung Cao; Elizabeth C Linton; Joshua Deitch; Simon Berritt; Marisa C Kozlowski
Journal:  J Org Chem       Date:  2012-12-04       Impact factor: 4.354

4.  Organocatalytic enantioselective tandem aldol-cyclization reaction of α-isothiocyanato imides and activated carbonyl compounds.

Authors:  Jie Guang; Cong-Gui Zhao
Journal:  Tetrahedron Asymmetry       Date:  2011-06-15

5.  Developing novel organocatalyzed aldol reactions for the enantioselective synthesis of biologically active molecules.

Authors:  Mayur Bhanushali; Cong-Gui Zhao
Journal:  Synthesis (Stuttg)       Date:  2011-06       Impact factor: 3.157

Review 6.  Molecular diversity of spirooxindoles. Synthesis and biological activity.

Authors:  Tetyana L Pavlovska; Ruslan Gr Redkin; Victoria V Lipson; Dmytro V Atamanuk
Journal:  Mol Divers       Date:  2015-09-29       Impact factor: 2.943

7.  Cu-catalyzed chemoselective preparation of 2-(pinacolato)boron-substituted allylcopper complexes and their in situ site-, diastereo-, and enantioselective additions to aldehydes and ketones.

Authors:  Fanke Meng; Hwanjong Jang; Byunghyuck Jung; Amir H Hoveyda
Journal:  Angew Chem Int Ed Engl       Date:  2013-04-03       Impact factor: 15.336

8.  Spirooxindole derivative SOID-8 induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells.

Authors:  Yan Tian; Sangkil Nam; Lucy Liu; Fumiko Yakushijin; Kenichi Yakushijin; Ralf Buettner; Wei Liang; Fan Yang; Yuelong Ma; David Horne; Richard Jove
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

9.  One-Step Synthesis of Chiral Oxindole-type Analogues with Potent Anti-inflammatory and Analgesic Activities.

Authors:  Yulong Sun; Jia Liu; Xianxing Jiang; Tao Sun; Luping Liu; Xiaoyuan Zhang; Shaoli Ding; Jingyi Li; Yan Zhuang; Yiqing Wang; Rui Wang
Journal:  Sci Rep       Date:  2015-09-01       Impact factor: 4.379

10.  Anti-cancer small molecule JP-8g exhibits potent in vivo anti-inflammatory activity.

Authors:  Yulong Sun; Jia Liu; Tao Sun; Xiaoyuan Zhang; Jia Yao; Ming Kai; Xianxing Jiang; Rui Wang
Journal:  Sci Rep       Date:  2014-03-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.